Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis

Clinical Research in Cardiology

Volumn 102, Issue 1, 2013, Pages 63-71

  Breda, L ^a   Di Marzio, D ^a   Giannini, C ^a   Gaspari, S ^a   Nozzi, M ^a   Scarinci, A ^a   Chiarelli, F ^a   Mohn, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerotic changes; Carotid intima media wall thickness; Children; Cytokines; Inflammation; Juvenile idiopathic arthritis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CHOLESTEROL BLOOD LEVEL; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; PRESCHOOL CHILD; PUBERTY; SCHOOL CHILD;

AGE FACTORS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; LIPIDS; LONGITUDINAL STUDIES; MALE; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEXUAL DEVELOPMENT; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84872318269     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0496-3     Document Type: Article

References (34)

1. Ravelli A, Martini A (2007) Juvenile idiophatic arthritis. Lancet 369:767-778
2. Woo P (2002) Cytokines and juvenile idiophatic arthritis. Curr Rheumatol Rep 4:452-457
3. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125-132
4. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957-2963
5. Maziere C, Auclair M, Maziere JC (1994) Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. FEBS Lett 338:43-46
6. del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833-1840
7. Järvisalo MJ, Jartti L, Näntö-Salonen K, Irjala K, Rönnemaa T, Hartiala JJ, Celermajer DS, Raitakari OT (2001) Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high risk children. Circulation 104:2943-2947
8. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ (2003) Carotid artery intimal-media thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111:61-66
9. Giannini C, de Giorgis T, Scarinci A, Ciampani M, Marcovecchio ML, Chiarelli F, Mohn A (2008) Obese related effects of inflammatory markers and insulin resistance on increased carotid intima-media thickness in pre-pubertal children. Atherosclerosis 197:448-456
10. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390-392
11. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202-1209
12. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581-593
13. Roberts LJ, Morrow JD (2000) Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513
14. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents 1996 Pediatrics 98(4 Pt 1):649-658
15. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406
16. Amato M, Montorsi P, Ravani A, Oldani E, Galli S, Ravagnani PM, Tremoli E, Baldassarre D (2007) Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J 28:2094-2101
17. Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND, Alfantaki S, Gartzonika K, Mavridis A, Michalis LK, Siamopoulou A (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res 63:1736-1744
18. von Känel R, Carney RM, Zhao S, Whooley MA (2012) Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study. Clin Res Cardiol 100:241-247
19. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH, Song CH, Lee J (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701-1704
20. Superko HR, Gadesam RR (2008) Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep 10:377-385
21. White D, Fayez S, Doube A (2006) Atherogenic lipid profiles in rheumatoid arthritis. N Z Med J 119:U2125
22. Praticò D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, FitzGerald GA (1997) Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 100:2637
23. Montuschi P, Barnes PJ, Roberts LA (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800
24. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38:366-371
25. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52:2293-2299
26. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:287-293
27. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:1074-1080
28. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed A (2009) Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 60:1496-1507
29. Nam BH, Kannel WB, D'Agostino RB (2006) Search for an optimal atherogenic lipid risk profile: from the Framingham-study. Am J Cardiol 97:372-375
30. Wang X, Feuerstein GZ, Gu JL, Lysko PG, Yue TL (1995) Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 115:89-98
31. Gonzalez-Juanatey C, Gonzalez-Gay MA (2004) Long-term rheumatoid arthritis and endothelial dysfunction. Atherosclerosis 176:197-198
32. Jacobsson LT, Turesson C, Gülfe A, Kapetanovic MC, Petersson IF, Saxne T, Geborek P (2005) Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32:1213-1218
33. Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, Gómez-Reino JJ (2007) All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 66:880-885
34. Tosetto A, Prati P, Baracchini C, Manara R, Rodeghiero F (2005) Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA project. J Thromb Haemost 3:1224-1230